Outcome Measures of Psoriasis in Clinical Trials: An Overview

Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 2

Abstract

Psoriasis is a common chronic inflammatory dermatological disorder resulting from interactions between genetic pre-disposition and triggering environmental factors. It affects approximately 1-3% of the population and poses a lifelong burden on those, affected. Psoriasis typically follows a relapsing and remitting course. It can occur at any age, although is uncommon in children (0.71%) but the majority of cases occur before 35 years. Psoriasis is associated with arthritis in a significant proportion of patients (reported in one study at 13.8%). Usually the psoriasis is not life threatening but it can be life ruining due to its visibility. In clinical trials, several outcome measures have been used to assess the severity of psoriasis. The common outcome measures include PASI (psoriasis area and severity index) score, Psoriasis Life Stress Inventory (PLSI), Psoriasis disability index (PDI), The National Psoriasis Foundation Psoriasis Score (NPF-PS), Physician Global Assessment (PGA), Self-Administered PASI (SAPASI), Simplified PASI (SPASI), Psoriasis Assessment Severity Score (PASS), Psoriasis Log-Based Area and Severity Index (PLASI), Psoriasis Exact Area and Severity Index (PEASI) and Beer Sheva Psoriasis Severity Score (BPSS). Among these, the PASI score is most popular and commonly used in clinical trials. To assess the quality of life in the patients of psoriasis the DLQI (dermatologic life quality index) is most commonly used in clinical trials. Several such instruments have been developed and continue to be developed to provide an assessment of the severity of the skin lesions. Since the skin lesions of psoriasis have an impact on quality of life of patients, there has been growing recognition of the need to measure the impact of the disease on quality of life along with the severity of the lesions.

Authors and Affiliations

Satyapal Singh

Keywords

Related Articles

Prevalence of Diabetic Macular Edema in association with Severity of Diabetic Retinopathy

Introduction: Diabetic eye disease is a leading cause of vision loss in persons aged 20 to 74 years.1Diabetic retinopathy is the most common microvascular complication of diabetes 2 , and can be broadly divided into two...

Molecular Cloning and Characterization of Pregnancy Specific Protein Uteroglobin can Lead to Pregnancy Detection in Cattle- A Review

Various kinds of approaches are treated of early pregnancy diagnosis for further aggravates the situation. Several methods of pregnancy diagnosis are being practiced in bovine species, yet none qualifies as the ideal pre...

Cross sectional Study of thyroid function and calcium in premenopausal and post menopausal women

Introduction: Hypothyroidism is seen to be common among women in these days. A cross sectional observational study was conducted to find out the S.TSH and calcium Levels in premenopausal and post-menopausal women Materia...

Effect of Short Term Naturopathy Interventions on Anemia: A Single Case Report

A 33 year old female diagnosed with iron deficiency Anemia in November 2014 visited National Institute of Naturopathy, OPD with complaints of lethargy, weakness, dry itchy skin and myalgia of shoulder and neck. She also...

Awareness of HIV/AIDS among Rural Population in Bathinda District of Punjab

A study was conducted to assess the awareness of HIV/AIDS among 300 rural peoples in the Bathinda district of Punjab. It was found that about 40% of rural people were aware about the transmission of HIV/AIDS through sexu...

Download PDF file
  • EP ID EP213243
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Satyapal Singh (2016). Outcome Measures of Psoriasis in Clinical Trials: An Overview. Journal of Medical Science And clinical Research, 4(2), 9298-9311. https://europub.co.uk/articles/-A-213243